T1	Intervention 0 23	Low-dose oral etoposide
T2	Intervention 164 182	low-dose etoposide
T3	Intervention 338 383	epipodophyllotoxins during frontline therapy.
T4	Intervention 434 541	patients received etoposide (50 mg/m(2) per day) administered orally as a single agent once or twice daily.
T5	Intervention 580 787	dexamethasone, vincristine, and L-asparaginase. Etoposide was administered until Day 22. Two courses of consolidation therapy were followed by continuation therapy or hematopoietic stem cell transplantation.
T6	Intervention 1230 1248	low-dose etoposide